These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9476759)

  • 1. Medication side effects in anxious patients: negative placebo responses?
    Uhlenhuth EH; Alexander PE; Dempsey GM; Jones W; Coleman BS; Swiontek AM
    J Affect Disord; 1998 Jan; 47(1-3):183-90. PubMed ID: 9476759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High doses alprazolam induced amenorrhoea and galactorrhoea.
    Petrić D; Peitl MV; Peitl V
    Psychiatr Danub; 2011 Mar; 23(1):123-4. PubMed ID: 21448116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical use of sustained release of alprazolam: A naturalistic study].
    De La Gándara Martín JJ; Sanz Granado O; Varona Martínez A; Such P
    Actas Esp Psiquiatr; 1999; 27(3):191-7. PubMed ID: 10431062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder.
    Schweizer E; Patterson W; Rickels K; Rosenthal M
    Am J Psychiatry; 1993 Aug; 150(8):1210-5. PubMed ID: 8328566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
    Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.
    Pecknold JC; Swinson RP; Kuch K; Lewis CP
    Arch Gen Psychiatry; 1988 May; 45(5):429-36. PubMed ID: 3282479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alprazolam-induced hypomania.
    Reddy J; Khanna S; Anand U; Banerjee A
    Aust N Z J Psychiatry; 1996 Aug; 30(4):550-2. PubMed ID: 8887708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms.
    Hoehn-Saric R; McLeod DR; Zimmerli WD
    J Clin Psychiatry; 1988 Aug; 49(8):293-301. PubMed ID: 3045099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, placebo-controlled, multicenter study with alprazolam and extended-release alprazolam in the treatment of panic disorder.
    Pecknold J; Luthe L; Munjack D; Alexander P
    J Clin Psychopharmacol; 1994 Oct; 14(5):314-21. PubMed ID: 7806686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy and tolerance of alprazolam and bromazepam in flexible doses. Double-blind study in 119 ambulatory anxious patients].
    Ropert R; Bernes J; Dachary JM
    Encephale; 1987; 13(2):89-95. PubMed ID: 2885173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alprazolam in the treatment of anxiety disorders and mixed anxiety and depressive disorders. Results of multicenter clinical trial].
    Kiejna A; Małyszczak K; Rzewuska M; Sobucka K; Florkowski A; Rajewski A; Rajewska J; Wojtanowska M; Dabkowski M; Brzeziński R; Rybakowski J; Sep-Kowalikowa B; Gałuszko P; Nowicki Z
    Psychiatr Pol; 1996; 30(6):973-92. PubMed ID: 9132771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alprazolam and oxazepam in the treatment of anxious out-patients with depressive symptoms: a double-blind multicenter study.
    Rimón R; Kultalahti ER; Kalli A; Koskinen T; Lepola U; Naarala M; Tick E
    Pharmacopsychiatry; 1991 May; 24(3):81-4. PubMed ID: 1891485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    Lydiard RB; Ballenger JC; Rickels K
    J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam.
    Klein E
    J Clin Psychiatry; 2002; 63 Suppl 14():27-33. PubMed ID: 12562116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alprazolam effects in children with anxiety disorders.
    Simeon JG; Ferguson HB
    Can J Psychiatry; 1987 Oct; 32(7):570-4. PubMed ID: 3315169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent use of buspirone in anxious patients during withdrawal from alprazolam therapy.
    Udelman HD; Udelman DL
    J Clin Psychiatry; 1990 Sep; 51 Suppl():46-50. PubMed ID: 2211568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder.
    Tesar GE; Rosenbaum JF; Pollack MH; Otto MW; Sachs GS; Herman JB; Cohen LS; Spier SA
    J Clin Psychiatry; 1991 Feb; 52(2):69-76. PubMed ID: 1993639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine.
    Klein E; Colin V; Stolk J; Lenox RH
    Am J Psychiatry; 1994 Dec; 151(12):1760-6. PubMed ID: 7977882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder.
    Enkelmann R
    Psychopharmacology (Berl); 1991; 105(3):428-32. PubMed ID: 1798836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching patients from alprazolam to clonazepam.
    Rosenbaum JF
    Hosp Community Psychiatry; 1990 Dec; 41(12):1302, 1305. PubMed ID: 2276722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.